Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Return on Capital Employed (2021 - 2025)

iSpecimen has reported Return on Capital Employed over the past 5 years, most recently at 2.96% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 2.96% for Q4 2025, down 15.0% from a year ago — trailing twelve months through Dec 2025 was 2.96% (down 15.0% YoY), and the annual figure for FY2025 was 2.8%, down 93.0%.
  • Return on Capital Employed for Q4 2025 was 2.96% at iSpecimen, up from 6.67% in the prior quarter.
  • Over the last five years, Return on Capital Employed for ISPC hit a ceiling of 0.23% in Q1 2022 and a floor of 8.68% in Q2 2025.
  • Median Return on Capital Employed over the past 5 years was 0.95% (2023), compared with a mean of 1.92%.
  • Biggest five-year swings in Return on Capital Employed: dropped -9bps in 2022 and later plummeted -708bps in 2025.
  • iSpecimen's Return on Capital Employed stood at 0.25% in 2021, then crashed by -89bps to 0.46% in 2022, then crashed by -141bps to 1.12% in 2023, then plummeted by -151bps to 2.81% in 2024, then decreased by -6bps to 2.96% in 2025.
  • The last three reported values for Return on Capital Employed were 2.96% (Q4 2025), 6.67% (Q3 2025), and 8.68% (Q2 2025) per Business Quant data.